Serum visfatin increases with progressive β-cell deterioration

Diabetes

Volumn 55, Issue 10, 2006, Pages 2871-2875

  López Bermejo, Abel ^a,b   Chico Julià, Berta ^a,b   Fernàndez Balsells, Mercè ^a,b   Recasens, Mònica ^a,b   Esteve, Eduardo ^a,b   Casamitjana, Roser ^c   Ricart, Wifredo ^a,b   Fernández Real, José Manuel ^a,b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; VISFATIN; CYTOKINE; PRE B CELL COLONY ENHANCING FACTOR, HUMAN; PRE-B-CELL COLONY-ENHANCING FACTOR, HUMAN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; B LYMPHOCYTE; BODY MASS; CONTROLLED STUDY; DETERIORATION; DIABETIC PATIENT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; PANCREAS ISLET BETA CELL; PATHOLOGY; SECRETION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED;

EID: 33750867485     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0259     Document Type: Article

References (17)

1. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I: Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14:1431-1437, 1994
2. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430, 2005
3. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M, Bluher M: Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911-2916, 2005
4. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ: Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91:295-299, 2006
5. Hammarstedt A, Pihlajamaki J, Sopasakis VR, Gogg S, Jansson PA, Laakso M, Smith U: Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 91:28-30, 2006
6. Arner P: Visfatin: a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 91:28-30, 2006
7. Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C: Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47:1757-1762, 1998
8. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G: Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 110:605-609, 2006
9. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R: Reduced plasma visfatin/pre B-cell colony enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91:3165-3170, 2006
10. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B: Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91:1578-1581, 2006
11. Bottcher Y, Teupser D, Enigk B, Berndt J, Kloting N, Schon MR, Thiery J, Bluher M, Stumvoll M, Kovacs P: Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat depot specific mRNA expression in humans. J Clin Endocrinol Metab 91:2725-2731, 2006
12. DeFronzo RA: Lilly Lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
13. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M: Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185:R1-R8, 2005
14. Guldstrand M, Ahren B, Adamson U: Improved beta-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557-E565, 2003
15. Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E: β-Cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 54:2382-2389, 2005
16. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
17. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M: The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909-1914, 2006